IP Library Granted Patent US 11,578,289
Granted Patent B2
US 11,578,289 · App. 16/741,062 · Granted Feb 14, 2023

Lipid extraction processes

Inventors: Nils Hoem (Oslo, NO); Asgeir Saebo (Eidsnes, NO)
Assignee: AKER BIOMARINE ANTARCTIC AS
C11B1/10A23G3/40A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,578,289
App. No.
16/741,062
Granted
Feb 14, 2023
Kind
B2
Abstract

The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.

Claims (11)

1. A composition comprising a solvent-extracted polar lipid-rich fraction from krill, said fraction comprising a protic solvent selected from the group consisting of n-butanol, n-propanol, isopropanol, ethanol, and methanol and a mixture of phospholipid compounds having the following structure:

wherein R1 and R2 are selected from the group consisting of a fatty acid moiety and —H and R3 is —H or a choline, ethanolamine, inositol or serine moiety,

wherein said mixture of phospholipid compounds comprises more than about 85% (mol %) choline moieties at position R3 and more than about 20% EPA and DHA combined at positions R1 and R2 and wherein the ratio of EPA:DHA is from 5:1 to 1:1, and

wherein said fraction comprises at least 50% phospholipids, and wherein said fraction is further characterized in having a conductivity of less than about 300 μS/cm measured in a saturated 60% ethanol solution.

2. The composition of claim 1 , wherein said fraction comprises at least 75% w/w of said phospholipid compounds.

3. The composition of claim 1 , wherein said fraction comprises at least 90% w/w of said phospholipid compounds.

4. The composition of claim 1 , wherein said fraction in said oral delivery capsule comprises at least 10% glyceride compounds comprising said omega-3 fatty acid moieties.

5. The composition of claim 1 , wherein said fraction comprises astaxanthin.

6. The composition of claim 5 , wherein said fraction has a astaxanthin monoester:astaxanthin diester ratio of greater than about 4:1.

7. The composition of claim 1 , wherein said fraction comprises less than about 0.05% w/w fatty acid esters.

8. The composition of claim 1 , wherein said fraction comprises less than 5% w/w lysophospholipids.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2024
From: AKER BIOMARINE ANTARCTIC AS
To: AKER BIOMARINE HUMAN INGREDIENTS AS
Reel/Frame 066703/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2021
From: AKER BIOMARINE AS
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 058135/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2021
From: HOEM, NILS; SAEBO, ASGEIR
To: AKER BIOMARINE AS
Reel/Frame 058121/0933 →
Continuity (4)
Continuation 14303835 · Jun 13, 2014
Provisional Application 61925931 · Jan 10, 2014
Provisional Application 61834965 · Jun 14, 2013
Related Publication 20200148972A1 · May 14, 2020